Friday, May 15, 2020

Further evidence does not support hydroxychloroquine for patients with COVID-19

The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia due to COVID-19, finds a study from France. And a randomized clinical trial from China shows that hospitalized patients with mild to moderate persistent covid-19 who received hydroxychloroquine did not clear the virus more quickly than those receiving standard care.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/05/200515174441.htm

No comments:

Post a Comment